"Lupus Nephritis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
| Descriptor ID |
D008181
|
| MeSH Number(s) |
C12.777.419.570.363.680 C13.351.968.419.570.363.680 C17.300.480.680 C20.111.590.560
|
| Concept/Terms |
Lupus Nephritis- Lupus Nephritis
- Lupus Glomerulonephritis
- Nephritis, Lupus
- Lupus Nephritides
- Nephritides, Lupus
- Glomerulonephritis, Lupus
- Glomerulonephritides, Lupus
- Lupus Glomerulonephritides
|
Below are MeSH descriptors whose meaning is more general than "Lupus Nephritis".
Below are MeSH descriptors whose meaning is more specific than "Lupus Nephritis".
This graph shows the total number of publications written about "Lupus Nephritis" by people in this website by year, and whether "Lupus Nephritis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 3 | 0 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2015 | 5 | 0 | 5 |
| 2016 | 3 | 0 | 3 |
| 2017 | 3 | 0 | 3 |
| 2019 | 2 | 1 | 3 |
| 2022 | 4 | 0 | 4 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lupus Nephritis" by people in Profiles.
-
Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis. Arthritis Rheumatol. 2024 Mar; 76(3):469-478.
-
Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium study. Pediatr Nephrol. 2022 12; 37(12):3139-3145.
-
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. Arthritis Rheumatol. 2022 02; 74(2):263-273.
-
Targeting MDM2 for novel molecular therapy: Beyond oncology. Med Res Rev. 2020 05; 40(3):856-880.
-
Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists. J Rheumatol. 2017 Nov; 44(11):1619-1623.
-
Clinical presentation and outcomes of childhood-onset membranous lupus nephritis. Pediatr Nephrol. 2017 Dec; 32(12):2283-2291.
-
Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Lupus. 2017 Mar; 26(3):299-306.
-
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):375-83.
-
The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus. Clin Exp Immunol. 2011 May; 164(2):227-35.
-
C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse. Mol Immunol. 2009 Apr; 46(7):1397-404.